2020-04-07 & 08 MAG Full Conference Calls

2020-04-07 & 08 MAG Full Conference Calls

Date: 

Part 1  Cancelled

Part 2 Joint AG Session, Allergy/adverse reaction concept model by substance and/or product  20:00UTC 08/04/2020

The rest topics will be covered by the future meetings.

Objectives

  • Review and agree actions on all currently active work items.

Zoom Details

https://snomed.zoom.us/j/535528933

Meeting ID: 535 528 933

International numbers available: https://snomed.zoom.us/zoomconference?m=7IB2eW_R_dNG29SLhsAq0sVKH1rcc2dQ

Recordings

 

Discussion items

Part 1 

120mins 

Description

Owner

Time

Notes

Action

Description

Owner

Time

Notes

Action

1

Meeting Introduction

 

@Peter Williams

10

Start Zoom Recording

Previous meeting (February 2020 full call): 2019-07-15 - Full MAG Meeting (Conf call)

End of term process, call for roll-offs. Call for interest post April meeting.

 

2

Concrete Domains 

 

@Peter Williams

30

Concrete Domains

SNOMED International Proposal for Representing Concrete Domains in RF2

Update on Consultation

How to represent Boolean?

 

3

BREAK

 

4

Requirements and solutions for analytics for historical records

@Peter Williams

@michael lawley

@Jeremy Rogers (Unlicensed)

@Kai Kewley

@Daniel Karlsson (Unlicensed)

@Guillermo Reynoso

@Yongsheng Gao

45

Historical Analytics

  1. Multiple queries run against successive releases of SNOMED with results collated.

  2. Update the EHRs to the latest concept using historical associations

  3. Create an enhanced transitive closure table containing inactive concepts at their last known position (but not children?)

  4. Augmented solution checks the position of replacement to determine concepts inactivated due to wrong placement.

Option here for a % confidence level and/or reason for inclusion to annotate results.

Should ECL / hosted services support this natively?

Is guidance around the issues and options (pros cons gotchas) the first thing to be done?

As always, soliciting the specific use cases would be very useful.

SPLG discussing changes to specifying substrate and access to the "Target" field in refsets eg the historical association.

 

5

MRCM topics

@Yongsheng Gao

@Guillermo Reynoso

@Ed Cheetham

@Kai Kewley

@Former user (Deleted)

 

MRCM management process Process for the maintenance of MRCM rules

MRCM management tool demo

MRCM diagram follow up MRCM diagrams

Release and version control for templates

 

6

Requirements and guidance for standalone SNOMED CT OWL documents

@Yongsheng Gao

@Former user (Deleted)

@Kai Kewley

 

  1. Inclusion of copyright text

  2. Ontology version

  3. Annotations including description types

  4. Language codes for annotations

 

Part 2 Joint Session with EAG and TRAG 

 

Description

Owner

Time

Notes

Action

Description

Owner

Time

Notes

Action

1

Introduction

@Peter Williams

@Jim Case

@Andrew Atkinson

5

Zoom + Start Recording

 

 

2

Basic Formal Ontology

@stefan.schulz (Unlicensed)

@Jim Case

@Daniel Karlsson (Unlicensed)

@Yongsheng Gao

@michael lawley

@Former user (Deleted)

40

Requirement to demonstrate benefit to implementers / end users if we are to fund a project on this

Review and feedback for the document at https://docs.google.com/document/d/1HcBj5bVIg8lB_uyORZU9A_FWKFsw0sxmB6Xg4UYKygk/edit#heading=h.izs8q5fkm2

MAG discussion here: Basic Formal Ontology Discussion

 

3

Observation and Evaluation Procedure

@Daniel Karlsson (Unlicensed)

@Jim Case

@Karim Nashar

40

 

 

4

Annotating concepts, axioms, and ontology

@Yongsheng Gao

@Jim Case

@Former user (Deleted)

@Kai Kewley

30

 

 

5

Degree of Synonym

@Jim Case

20

Requirement for a new description type (as discussed by EAG) for terms that are not very synonymous.

 

6

Allergy/adverse reaction concept model by substance and/or product

@Yongsheng Gao

@Bruce Goldberg

@Jim Case

@Former user (Deleted)

@Farzaneh Ashrafi

30

 

7

TRAG items of potential interest

@Peter Williams

@Jim Case

 

10

Reference set metadata See Agenda item 17 and consider in wider context of machine readable metadata item 11. Traction has been lost, is a sub-group needed to progress?

FSNs greater than 255 characters eg for vaccine concepts. Steer from SI is that we don't want to be changing RF2 description limits for the sake of a single use case.

Additional item: some refsets should not contain inactive concepts. This should be part of the metadata.

ISO language/dialect code where applicable

8

Versioning of Templates

@Guillermo Reynoso

5

From the EAG: Templates are becoming first class citizens and would be useful to other members. They should be given unique identifiers, packaged and versioned like any other RF2 component.

 

9

Revisit "Negative Delta"

@Peter Williams

@Andrew Atkinson

5

At request of EAG - need to revoke/delete a published component. Comments added to Negative Delta.

See TRAG agenda item #TBC

@Peter Williams Write parent page to capture various options in one place. Add pros/cons.
@Andrew Atkinson to update critical incident policy to list actions based on particular use cases, once approach agreed.

Use cases:

Two categories: where audit is desired (eg technical issue) and where it is not (IP, un-processable characters)

  1. Removing IP - suggestion to blank out particular field ("~") while leaving row.

  2. Conflicting Rows ie no clear state (technical issue, not content) - suggestion to subsequent delta clarifying row.

  3. Clinically dangerous historical error in before-previous release. Does that become more or less of a problem with frequent releases? Fixed quicker, but we lose ability to recall and re-publish.

GR: If the fault can be subsequently fixed in the Snapshot eg by restating the correct state with a new effectiveTime, then that could be considered sufficient.

Insufficient Time

Description

Owner

Time

Notes

Action

Description

Owner

Time

Notes

Action

1

 

 

 

 

 

2

Modularizing the core and/or Migrating content to a dependant module

@Peter Williams

@Jeremy Rogers (Unlicensed)

45

Check for EAG discussion on same.

@michael lawley is the previous work you did on module composition (as opposed to dependency) available?

Use cases:

  1. Return of content to the UK Edition,

  2. Separation of clinical core from "Community Content"

Content would need to be inactivated in the International Edition and then the same identifiers would be re-activated in the next UK Edition using their own module. FYI @Jeremy Rogers (Unlicensed)

The apparent "break in time" can be resolved by detection of the "Concept Moved Elsewhere" inactivation indicator and the historical association to the concept representing the receiving namespace.

Actually, it's easier to move to another edition than it is to move within the same release. Would we end up with an active concept in one module, and an active inactivation indicator in the other?

The receiving module should inactivate both the inactivation indicator and the historical association - agree?

The inactivation and reactivation in a new module within a single package is going to be very noisy. Can we make a clean cut and just restate the new modules?

 

Previous work on Module Composition - discussion including link to my proposal https://snomed.atlassian.net/wiki/x/eIL8Bw

Potential Attendees

userlister.notpermitted.viewuserprofile
userlister.notpermitted.viewuserprofile
userlister.notpermitted.viewuserprofile
userlister.notpermitted.viewuserprofile

Attending via Zoom

Apologies

  •  

Previous Meetings

TitleCreatorModified
No content found.

Meeting Files

 

 

Copyright © 2025, SNOMED International